Name | Number of supported studies | Average coverage | |
---|---|---|---|
basal cell | 4 studies | 18% ± 3% | |
conventional dendritic cell | 3 studies | 27% ± 9% | |
non-classical monocyte | 3 studies | 24% ± 7% | |
B cell | 3 studies | 18% ± 0% | |
epithelial cell | 3 studies | 35% ± 5% | |
dendritic cell | 3 studies | 33% ± 9% | |
natural killer cell | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 3 studies | 21% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2153.83 | 1445 / 1445 | 100% | 17.65 | 183 / 183 |
lung | 100% | 2378.06 | 578 / 578 | 100% | 23.15 | 1155 / 1155 |
ovary | 100% | 2266.43 | 180 / 180 | 100% | 20.22 | 430 / 430 |
prostate | 100% | 2141.97 | 245 / 245 | 100% | 16.79 | 502 / 502 |
stomach | 100% | 1917.13 | 359 / 359 | 100% | 23.19 | 286 / 286 |
brain | 100% | 1872.88 | 2637 / 2642 | 100% | 24.58 | 705 / 705 |
intestine | 100% | 2121.48 | 966 / 966 | 100% | 25.20 | 526 / 527 |
bladder | 100% | 2732.38 | 21 / 21 | 100% | 24.60 | 503 / 504 |
skin | 100% | 2979.08 | 1809 / 1809 | 100% | 26.37 | 471 / 472 |
uterus | 100% | 2137.71 | 170 / 170 | 100% | 21.26 | 458 / 459 |
liver | 100% | 2202.69 | 226 / 226 | 100% | 16.88 | 405 / 406 |
breast | 100% | 2620.86 | 459 / 459 | 100% | 19.44 | 1115 / 1118 |
pancreas | 100% | 1671.01 | 327 / 328 | 100% | 21.97 | 178 / 178 |
thymus | 100% | 2219.62 | 653 / 653 | 100% | 19.03 | 602 / 605 |
kidney | 100% | 1796.93 | 89 / 89 | 99% | 16.37 | 894 / 901 |
adrenal gland | 100% | 1720.83 | 258 / 258 | 94% | 13.01 | 217 / 230 |
adipose | 100% | 2943.91 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2525.23 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 35.19 | 29 / 29 |
spleen | 100% | 2244.57 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 14.69 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.22 | 1 / 1 |
muscle | 100% | 2322.40 | 800 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 19.23 | 79 / 80 |
heart | 96% | 1293.48 | 825 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 1739.76 | 865 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031641 | Biological process | regulation of myelination |
GO_0045927 | Biological process | positive regulation of growth |
GO_0061564 | Biological process | axon development |
GO_0006397 | Biological process | mRNA processing |
GO_0021510 | Biological process | spinal cord development |
GO_0033120 | Biological process | positive regulation of RNA splicing |
GO_0071364 | Biological process | cellular response to epidermal growth factor stimulus |
GO_0007165 | Biological process | signal transduction |
GO_0001833 | Biological process | inner cell mass cell proliferation |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_1990261 | Biological process | pre-mRNA catabolic process |
GO_0042307 | Biological process | positive regulation of protein import into nucleus |
GO_0030576 | Biological process | Cajal body organization |
GO_0006260 | Biological process | DNA replication |
GO_0006457 | Biological process | protein folding |
GO_0008380 | Biological process | RNA splicing |
GO_0000226 | Biological process | microtubule cytoskeleton organization |
GO_2000672 | Biological process | negative regulation of motor neuron apoptotic process |
GO_0042023 | Biological process | DNA endoreduplication |
GO_0001834 | Biological process | trophectodermal cell proliferation |
GO_1902742 | Biological process | apoptotic process involved in development |
GO_0045787 | Biological process | positive regulation of cell cycle |
GO_0005730 | Cellular component | nucleolus |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0043204 | Cellular component | perikaryon |
GO_0005654 | Cellular component | nucleoplasm |
GO_0043025 | Cellular component | neuronal cell body |
GO_0030426 | Cellular component | growth cone |
GO_0005737 | Cellular component | cytoplasm |
GO_0015030 | Cellular component | Cajal body |
GO_0097504 | Cellular component | Gemini of coiled bodies |
GO_0030424 | Cellular component | axon |
GO_0005634 | Cellular component | nucleus |
GO_0031369 | Molecular function | translation initiation factor binding |
GO_0044183 | Molecular function | protein folding chaperone |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
Gene name | ZPR1 |
Protein name | Zinc finger protein ZPR1 (Zinc finger protein 259) ZPR1 zinc finger |
Synonyms | ZNF259 |
Description | FUNCTION: Acts as a signaling molecule that communicates proliferative growth signals from the cytoplasm to the nucleus. It is involved in the positive regulation of cell cycle progression . Plays a role for the localization and accumulation of the survival motor neuron protein SMN1 in sub-nuclear bodies, including gems and Cajal bodies. Induces neuron differentiation and stimulates axonal growth and formation of growth cone in spinal cord motor neurons. Plays a role in the splicing of cellular pre-mRNAs. May be involved in H(2)O(2)-induced neuronal cell death. . |
Accessions | F8WBC5 H7BZS1 ENST00000429220.5 H7BZM7 O75312 H7C449 ENST00000425791.1 ENST00000449430.1 ENST00000444935.5 ENST00000227322.8 H7C0E5 ENST00000431973.5 |